In a patient with a synchronous prostate cancer and non-invasive urothelial carcinoma limited to the prostatic urethra is complete TUR and definitive prostate dose to standard prostate fields adequate treatment?

Is a field effect bladder recurrence a concern? Shoud BCG to bladder be considered?